Sharing Experiences and Information about Elzonris (tagetreotide) for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Elzonris (tagetreotide) is a medication used to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and aggressive type of blood cancer. Given as an injection, Elzonris target…